VanEck Avalanche ETF (VAVX) news
Recent news
Tavexia Lifecare - Board approves acquisition of 60% controlling stake in Meyonex Pharmaceuticals
Tavexia Lifecare Limited (TAVX) has announced that its board of directors has approved the acquisition of a 60% controlling stake in Meyonex Pharmaceuticals. The move is expected to strengthen Tavexia’s position in the pharmaceutical sector by expanding its product portfolio and enhancing its…
AInvest Wire · 1d agoAVAX SA - Final investment decision on the project expected before the end of 2026
Investors and analysts are closely monitoring the trajectory of AVAX as the year 2026 progresses, with a final investment decision on the project expected before the end of the year. As of August 2026, AVAX is trading at approximately $9–$12, having experienced a significant decline from its…
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.